Promoter construct for gene expression in neuronal cells

Details Promoter construct for gene expression in neuronal cells Promoter construct for gene expression in neuronal cells

2003-04-02

2008-03-11

Woitach, Joseph (Department: 1633)

Chemistry: molecular biology and microbiology

Micro-organism, tissue cell culture or enzyme using process...

Recombinant dna technique included in method of making a...

C536S023100, C536S024100, C435S320100, C435S325000

Reexamination Certificate

active

07341847

ABSTRACT:
The invention relates to a chimeric promoter construct useful for neuronal cell specific gene expression. The invention provides a recombinant nucleic acid molecule that comprises a neuronal cell specific promoter such as platelet-derived growth factor β-chain promoter, operably linked to a heterologous enhancer which enhances the transcriptional activity of the promoter, such as cytomegalovirus immediate early gene enhancer. The promoter construct according to the invention can increase and prolong gene expression in neuronal cells and may be advantageously used in gene therapy of neuronal disorders.

REFERENCES:
patent: 5168062 (1992-12-01), Stinski
patent: 5310660 (1994-05-01), Bitter
patent: 5424411 (1995-06-01), Yagi et al.
patent: 5559027 (1996-09-01), Filmus et al.
patent: 5763217 (1998-06-01), Cynader et al.
patent: 5811633 (1998-09-01), Wadsworth et al.
patent: 5849522 (1998-12-01), Fleckenstein et al.
patent: 5859331 (1999-01-01), Maas et al.
patent: 5877399 (1999-03-01), Hsiao et al.
patent: 5981274 (1999-11-01), Tyrrell et al.
patent: 6066726 (2000-05-01), Farb et al.
patent: 6180613 (2001-01-01), Kaplitt et al.
patent: 6218140 (2001-04-01), Fleckenstein et al.
patent: 6261834 (2001-07-01), Srivastava
patent: 6320038 (2001-11-01), Panula et al.
patent: 2002/0090719 (2002-07-01), Yew
Hardy et al., Review, Science, 1998, 282: 1075-1079.
Fisher et al., Review, Cell Mol Biol, 2001, 47: 1269-1275.
Gardlik et al., Review, Med Sci Monit, 2005, 11: RA110-121.
Tuszynski, Review, gene Therapy, 2003, 3: 815-828.
Zhang et al., Molecular Brain Research, 2000, 84: 17-31.
Xu et al., Hum Gene Ther, 2001, 12: 563-573.
Peel et al., Gene Therapy, 1997, 4: 16-24.
Huang et al., Hum Gene Therapy, 2001, 12: 1731-1740.
Barnhart et al., Hum Gene Therapy, 1998, 9: 2545-2553.
Bromberg et al., Methods in Enzymology, 2002, 346: 199-224.
Submilla et al., Am J Physiol, 1999, 277: H2381-2391.
Muller et al., FASEB J, 2000, 14: 2540-2548.
Latham et al., Cancer Research, 2000, 60: 334-341.
Meyer et al., Review, Cell. Mol. Biol., 2001, 47: 1277-1294.
Lowenstein et al., Review, Current Opinion in Pharmacology, 2004, 4: 91-97.
Fukuchi, K., et al. Activity Assays of Nine Heterogeneous Promoters In Neural and Other Cultured Cells.In Vitro Cellular&Development Biology(1994) 30A(5):300-5.
Thiel, G. et al. Characterization of Tissue-specific Transcription by the Human Synapsin I Gene Promoter.Proceedings of the National Academy of Science(1991) 88:3431-35. (See particularly Abstract and p. 3433, left hand column, line 26-47).
Haberman, R. P. et al. Differential neuronal gene expression from two non-specific promoters after recombinant adeno-associated virus (rAAV) 2 transduction in vivo.Society for Neuroscience Abstracts, (2001), vol. 27, No. 2, pp. 2345.
Zhang, G. et al. A tyrosine hydroxylase-neurofilament chimeric promoter enhances long-term expression in rat forebrain neurons from helper virus-free HSV-1 vectors. (2000)Molecular Brian Research84:17-31. (see p. 18, right hand column, line 12-23, and Figure 1.
Gerdes C.A. et al. “Strong Promoters Are the Key to Highly Efficient, Noninflammatory and Noncytotoxic Adenoviral-Mediated Transgene Delivery into the Brain in Vivo”.Molecular Therapy, vol. 2, No. 4, Oct. 2000, 330-338.
Khachigian, L, M. et al. Novel cis-Acting Elements in the Human Platelet-derived Growth Factor B-chain Core Promoter That Mediate Gene Expression in Cultured Vascular Endothelial Cells.The Journal of Biological Chemistry, 1994, vol. 269, No. 36, 22647-22656.
Klein R. L. et al. Neuron-Specific Transduction in the Rat Septohippocampal or Nigrostriatal Pathway by Recombinant Adeno-associated Virus Vectors.Experimental Neurology, 1998, 150:183-94.
Miller N. et al. “Targeted vectors for gene therapy”.FASEB J1995, 9: 190-199.
Miller N. et al. “Progress in Transcriptionally Targeted and Regulatable Vectors for Genetic Therapy”.Human Gene Therapy, 1997, 8: 803-815.
Niwa, H. et al. “Efficient selection for high-expression transfectants with a novel eukaryotic vector:”Gene1991, 108: 193-199.
Robinson, D. et al. “Retroviral vector with a CMV-IE/HIV-TAR hybrid LTR gives high basal expression levels and is up-regulated by HIV-1 Tat”.Gene Therapy, 1995, 2: 269-278.
Sasahara, M. et al. “PDGF B-chain in Neurons of the Central Nervous System, Posterior Pituitary, and in a Transgenic Model”.Cell1991, 64: 217-227.
Sawicki, J.A. et al. “A Composite CMV-IE Enhancer/β-Actin Promoter is Ubiquitously Expressed in Mouse Cutaneous Epithelium”.Experimental Cell Research, 1998, 244:367-369.
Yew, N. S. “Optimization of Plasmid Vectors for High-Level Expression in Lung Epithelial Cells”.Human Gene Therapy, 1997, 8: 575-584.
Yew, N. S. “High and Sustained Transgene Expression in Vivo from Plasmid Vectors Containing a Hybrid Ubiquitin Promoter”.Molecular Therapy, 2001, 4: 75-82.
Paterna, J.C., et al. “Influence of promoter and WHV post-transcriptional regulatory element on AAV-mediated transgene expression in the rat brain”.Gene TherAug. 2000; 7(15): 1304-11.
Luebke, A.E., et al “Cochlear Function and Transgene Expression in the Guinea Pig Chochlea, Using Adenovirus- and Adeno-Associated Virus-Directed Gene Transfer”.Human Gene Therapy12:773-81 (May 1, 2001).
Mori, K., et al. “Intraocular Adenoviral Vector-Mediated Gene Transfer in Proliferative Retinopathies”.Investigative Opthalmology&Visual Science, May 2002, vol. 43, No. 5, 1610-1615.
Hagstrom, J. N. et al. “Improved muscle-derived expression of human coagulation factor IX from a skeletal actin/CMV hybrid enhancer/promoter”.Blood, Apr. 15, 2000, vol. 95, No. 8, 2536-2542.
Barnhart, K.M. et al Enhancer and Promoter Chimeras in Plasmids Designed for Intramuscular Injection: A Comparative In Vivo and In Vitro Study.Human Gene Therapy9:2545-2553 (Nov. 20, 1998).
Factor P. “Gene Therapy for Acute Diseases”Molecular Therapy, vol. 4, No. 5, Dec. 2001, 515-524.

Affiliated with

Also associated with

Rating

Promoter construct for gene expression in neuronal cells does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Promoter construct for gene expression in neuronal cells, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Promoter construct for gene expression in neuronal cells will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3973795